Step Stone Group LP Imago Bio Sciences, Inc. Transaction History

Step Stone Group LP

  • $245 Million
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
BUY
$16.0 - $28.84 $8.37 Million - $15.1 Million
522,987 New
522,987 $10.5 Million

Others Institutions Holding IMGO

# of Institutions
2
Shares Held
19.3K
Call Options Held
0
Put Options Held
0
View Full List

About Imago BioSciences, Inc.

IMGO Quotes by TradingView
  • Ticker IMGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,741,600
  • Description
  • Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment o...
More about IMGO
Track This Portfolio

Track Step Stone Group LP Portfolio

Follow Step Stone Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Step Stone Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Step Stone Group LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email